UK life sciences being held back by lack of institutional investment
By Stuart Rose, CEO, OBN (UK) Ltd
The UK life sciences sector is world-class, but we’re still not backing it with the capital it deserves. The Government’s pledge over the weekend to back the science and technology sector with up to £86bn of funding over the current Parliament is most welcome.
Despite producing 8.2% of the world’s most-cited researchers and hosting 4 of the top 10 global universities, our institutional investors, particularly pension funds, are missing in action. In fact, Canadian pensions invest more in UK life sciences than our own do.
Stuart Rose explores why this matters, what the Mansion House Accord could mean for the sector, and why now is the time to turn our research excellence into real-world innovation and impact.
Related News
